Mono Pharmacare Stock Screener | Share Price & Fundamental Analysis
MONOPHARMA
Pharmaceuticals
Screen Mono Pharmacare share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹26.86 Cr.
P/B Ratio
0.85
EPS (TTM)
₹1.75
Dividend Yield
-
Debt to Equity
1.60
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹110.00
Total Equity
₹31.00
Mono Pharmacare Share Price History - Stock Screener Chart
Screen MONOPHARMA historical share price movements with interactive charts. Analyze price trends and patterns.
Mono Pharmacare Company Profile - Fundamental Screener
Screen Mono Pharmacare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MONOPHARMA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0OIP01012
Mono Pharmacare Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen MONOPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Total Assets | 110 | 81 | 63 |
| Current Assets | 109 | 80 | 61 |
| Fixed Assets | 1 | 1 | 1 |
| Liabilities | |||
| Total Liabilities | 110 | 81 | 63 |
| Current Liabilities | 26 | 17 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 31 | 28 | 13 |
| Share Capital | 18 | 18 | 12 |
| Reserves & Surplus | 14 | 10 | 1 |
Screen MONOPHARMA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March |
|---|---|---|---|---|
| Revenue | 0 | 169 | 122 | 27 |
| Expenses | 0 | 161 | 116 | 26 |
| EBITDA | 0 | 9 | 6 | 2 |
| Operating Profit % | 0.00% | 5.00% | 5.00% | 6.00% |
| Depreciation | 0 | 0 | 0 | 0 |
| Interest | 0 | 4 | 3 | 1 |
| Profit Before Tax | 0 | 5 | 3 | 1 |
| Tax | 0 | 1 | 1 | 0 |
| Net Profit | 0 | 3 | 3 | 1 |
| EPS | 0.00 | 1.75 | 1.59 | 0.71 |
Mono Pharmacare Cash Flow Screener - Liquidity Fundamentals
Screen MONOPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | -4 | -9 | -28 |
| Investing Activities | 0 | 0 | -1 |
| Financing Activities | 5 | 8 | 30 |
| Net Cash Flow | 0 | 0 | 0 |
Screen MONOPHARMA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Apr | 2023-Aug | 2023-Sept | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 56.72% | 56.72% | 56.72% | 56.72% | 81.03% | 81.03% | 56.72% | 56.72% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 35.60% | 34.48% | 36.69% | 35.27% | 0.00% | 0.00% | 38.13% | 37.21% |
| Other Holding | 7.68% | 8.80% | 6.59% | 8.01% | 18.97% | 18.97% | 5.14% | 6.07% |
| Shareholder Count | 478 | 514 | 418 | 463 | 17 | 17 | 972 | 528 |
Mono Pharmacare Dividend Screener - Share Yield Analysis
Screen MONOPHARMA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Mono Pharmacare Index Membership - Market Screener Classification
Screen MONOPHARMA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Mono Pharmacare Market Events Screener - Corporate Actions
Screen MONOPHARMA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 8.53% | ||
| 2025-11-29 | 2025-11-29 | Quarterly Result Announcement | NA | 10.25% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 11.83% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -2.23% |
Mono Pharmacare Competitors Screener - Peer Comparison
Screen MONOPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Mono Pharmacare Company Announcements - News Screener
Screen MONOPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.